research Permanent chemotherapy-induced nonscarring alopecia and premature ovarian failure 5 citations , March 2015 in “Clinical and Experimental Dermatology” Chemotherapy caused a woman's permanent hair loss and early menopause.
research Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia. September 2025 in “PubMed” Prevent persistent hair loss after chemotherapy with scalp cooling and early minoxidil use.
research Low‐dose oral minoxidil as treatment for non‐scarring alopecia: a systematic review 19 citations , June 2020 in “International Journal of Dermatology” Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.
research Treatment of diseases associated with non-cicatricial alopecia 2 citations , January 2021 in “Przegląd Dermatologiczny (1959)” The article discusses various treatments for different types of non-scarring hair loss.
research Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review 34 citations , January 2018 in “International Journal of Dermatology” Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.
community DUPA VS. FAPD, which is more treatable? Which is worse? in Research/Science 8 upvotes 1 year ago DUPA is considered more treatable than FAPD, as FAPD involves scarring that prevents hair regrowth. The user has started treatment with oral dutasteride and minoxidil, hoping for better results than previous treatments.